Enakshi Singh - Aug 12, 2022 Form 4 Insider Report for Zymergen Inc. (ZY)

Signature
/s/ Celeste Ferber, attorney-in-fact
Stock symbol
ZY
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/15/2022, 07:49 PM
Previous filing
Mar 15, 2022
Next filing
Sep 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZY Common Stock Award $0 +8.32K +1.74% $0.00 485K Aug 12, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units (RSUs) that vest (i) with respect to 50% of the total underlying amount immediately prior to the consummation of the merger contemplated by the Agreement and Plan of Merger ("Merger Agreement") dated July 24, 2022 by and between the Issuer, Ginkgo Bioworks Holdings, Inc. and certain other parties named therein (the date on which the consummation of the Merger occurs, the "Closing Date") and (ii) with respect to the remaining 50% of the total underlying amount, on the six-month anniversary of the Closing Date, subject to the grantee's continuous service through each such vesting date; provided that the RSUs accelerate upon the occurrence of certain qualifying events.
F2 Includes 77,000 RSUs that vest 1/3 on November 1, 2022 and the remaining 2/3 on November 1, 2023, subject to the Reporting Person's continued service to the Company through thevesting date, and 250,000 RSUs that vest 1/24 on each monthly anniversary of the first day of the calendar month immediately following the Grant Date, March 11, 2022, subject to thegrantee's continuous service through each such vesting date